Cure8 research brief
This study suggests a plant polysaccharide (AMKP) can directly stimulate goblet cells to secrete MUC2 and reduce colitis in mice without relying on gut microbes, pointing to a new microbiota-independent approach for restoring the mucus barrier in ulcerative colitis.
Researchers in mucosal biology and IBD, translational scientists exploring non-microbial therapies for UC, and clinicians following emerging preclinical IBD research.
The paper identifies a small inulin-type fructan from Atractylodes macrocephala (AMKP) and shows it reduced disease signs in a DSS colitis mouse model while increasing MUC2 expression.
The authors tested whether gut microbes were required by depleting microbiota with broad antibiotics; AMKP’s benefits and MUC2 induction persisted, supporting a microbiota-independent effect. In cultured LS174T goblet-like cells, AMKP directly promoted MUC2 synthesis and secretion.
Mechanistic experiments link the effect to activation of autophagy and reduction of endoplasmic reticulum (ER) stress; blocking autophagy prevented the protective effect, implicating an autophagy–MUC2 axis. This is preclinical, mechanistic work (mouse model + cell lines).
It suggests a potential new therapeutic approach but does not provide human safety or efficacy data.
Results are preclinical (mouse DSS model and cultured goblet cells) and based on the article abstract. Human safety and efficacy are not addressed; further validation and clinical studies are needed.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This preclinical study identifies a plant-derived polysaccharide that reduced inflammation and improved gut barrier function in a mouse model of colitis and points to microbiome changes and an S100A8/A9–NF‑κB pathway as...
People with ulcerative colitis may be interested because the study describes a natural compound that reduced inflammation and disease signs in a mouse model and acted through the gut microbiota and immune pathways —...
A plant polysaccharide (PVP) reduced inflammation and preserved intestinal barrier proteins in a mouse model of ulcerative colitis, apparently by increasing a specific gut bacterium. This points to a microbiome-related...
